| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 6, Issue 2 185-190, Copyright © 1995 by American Association of Cancer Research
ARTICLES |
JR Flanagan
Department of Internal Medicine, University of Iowa, Iowa City 52246, USA.
YY1 is believed to be a constitutive factor, present in all cell types, affecting the transcription of a large number of genes. Experiments in this report demonstrated that YY1 RNA expression in NIH3T3 cells was modulated by media factors, either exogenously added to the media or elaborated by the NIH3T3 cells themselves. This autologous stimulation of YY1 expression was in proportion to the density of cells and was time dependent. Sparsely plated cells lost YY1 RNA expression within hours after being placed under fresh, serum-free media and lost YY1 protein expression by 24 h. Subsequent recurrence of YY1 expression in serum-deprived NIH3T3 cells was significantly decreased by adding monoclonal anti-insulin-like growth factor (IGF)-1 to the media. Radioimmunoassay showed that NIH3T3 cells secreted IGF-1 into the media for up to 72 h after being deprived of serum in the media but did not do so after they became quiescent. In quiescent NIH3T3 cells, YY1 expression was low or absent but was rapidly stimulated by exposure of the quiescent cells to media-containing serum. Exogenous growth factors, either whole serum or purified IGF-1, stimulated YY1 expression equally well. The rapid responses of YY1 expression to growth factor deprivation and replacement suggested the possibility that YY1 may mediate some of the intranuclear responses to autologous stimulation by IGF-1.
This article has been cited by other articles:
![]() |
Q. Liu, K. A. Merkler, X. Zhang, and M. P. McLean Prostaglandin F2{alpha} Suppresses Rat Steroidogenic Acute Regulatory Protein Expression via Induction of Yin Yang 1 Protein and Recruitment of Histone Deacetylase 1 Protein Endocrinology, November 1, 2007; 148(11): 5209 - 5219. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Shestakova, Z. Mansuroglu, H. Mokrani, N. Ghinea, and E. Bonnefoy Transcription factor YY1 associates with pericentromeric {gamma}-satellite DNA in cycling but not in quiescent (G0) cells Nucleic Acids Res., August 17, 2004; 32(14): 4390 - 4399. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. P. Tan, K. Nonaka, G. H. Nuckolls, Y. H. Liu, R. E. Maxson, H. C. Slavkin, and L. Shum YY1 activates Msx2 gene independent of bone morphogenetic protein signaling Nucleic Acids Res., March 1, 2002; 30(5): 1213 - 1223. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Coull, F. Romerio, J.-M. Sun, J. L. Volker, K. M. Galvin, J. R. Davie, Y. Shi, U. Hansen, and D. M. Margolis The Human Factors YY1 and LSF Repress the Human Immunodeficiency Virus Type 1 Long Terminal Repeat via Recruitment of Histone Deacetylase 1 J. Virol., August 1, 2000; 74(15): 6790 - 6799. [Abstract] [Full Text] |
||||
![]() |
M. Austen, B. Luscher, and J. M. Luscher-Firzlaff Characterization of the Transcriptional Regulator YY1. THE BIPARTITE TRANSACTIVATION DOMAIN IS INDEPENDENT OF INTERACTION WITH THE TATA BOX-BINDING PROTEIN, TRANSCRIPTION FACTOR IIB, TAFII55, OR cAMP-RESPONSIVE ELEMENT-BINDING PROTEIN (CBP)-BINDING PROTEIN J. Biol. Chem., January 17, 1997; 272(3): 1709 - 1717. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Wu and A. S. Lee YY1 as a Regulator of Replication-dependent Hamster Histone H3.2 Promoter and an Interactive Partner of AP-2 J. Biol. Chem., January 5, 2001; 276(1): 28 - 34. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Petkova, M. J. Romanowski, I. Sulijoadikusumo, D. Rohne, P. Kang, T. Shenk, and A. Usheva Interaction between YY1 and the Retinoblastoma Protein. REGULATION OF CELL CYCLE PROGRESSION IN DIFFERENTIATED CELLS J. Biol. Chem., March 9, 2001; 276(11): 7932 - 7936. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |